Status:
COMPLETED
Preoperative Bevacizumab Injection in Primary Pterygium in Tunisian Patients
Lead Sponsor:
University Hospital Fattouma Bourguiba
Conditions:
Pterygium
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Purpose: To assess the efficacy and safety of a single preoperative intra-lesional bevacizumab injection in primary pterygium. Methods: The investigators conducted a randomized controlled interventio...
Detailed Description
This prospective randomized controlled study adhered to the tenets of the Declaration of Helsinki. The Ethics Committee of our institution approved its modalities. The investigators had informed conse...
Eligibility Criteria
Inclusion
- clinical diagnosis of primary pterygium (stages 2,3 and 4) with surgical indication.
Exclusion
- unable to attend the whole follow-up
- Bevacizumab contraindications (hypertension, bleeding tendencies, previous myocardial infarction or stroke, pregnant and lactating women).
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05314673
Start Date
January 1 2019
End Date
January 1 2021
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dhouha Gouider
Aryanah, Illinois, Tunisia, 2037